Healthcare provider profile · identity verified

Elisel Vera-Galvan, M.D.

Internal Medicine · NEW PORT RICHEY, FL · NPI 1992747174

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1081	341
Losartan Potassium	Losartan Potassium	645	196
Gabapentin	Gabapentin	511	139
Levothyroxine Sodium	Levothyroxine Sodium	384	124
Metformin Hcl	Metformin Hcl	371	111
Rosuvastatin Calcium	Rosuvastatin Calcium	354	117
Omeprazole	Omeprazole	333	131
Amlodipine Besylate	Amlodipine Besylate	331	127
Hydrochlorothiazide	Hydrochlorothiazide	328	120
Famotidine	Famotidine	323	116
Vitamin D2	Ergocalciferol (Vitamin D2)	301	118
Fluticasone Propionate	Fluticasone Propionate	294	115
Xarelto	Rivaroxaban	294	54
Metoprolol Succinate	Metoprolol Succinate	276	104
Sildenafil Citrate	Sildenafil Citrate	276	69
Lisinopril	Lisinopril	264	81
Eliquis	Apixaban	263	51
Tamsulosin Hcl	Tamsulosin Hcl	253	86
Simvastatin	Simvastatin	194	61
Furosemide	Furosemide	192	66
Pantoprazole Sodium	Pantoprazole Sodium	186	77
Clopidogrel	Clopidogrel Bisulfate	178	63
Metoprolol Tartrate	Metoprolol Tartrate	166	62
Carvedilol	Carvedilol	159	41
Albuterol Sulfate Hfa	Albuterol Sulfate	153	44
Glipizide	Glipizide	153	44
Mirtazapine	Mirtazapine	147	44
Warfarin Sodium	Warfarin Sodium	136	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	133	41
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	124	34
Entresto	Sacubitril/Valsartan	115	16
Montelukast Sodium	Montelukast Sodium	106	43
Folic Acid	Folic Acid	105	39
Metformin Hcl Er	Metformin Hcl	104	29
Glipizide Er	Glipizide	102	31
Tizanidine Hcl	Tizanidine Hcl	100	46
Alendronate Sodium	Alendronate Sodium	99	53
Valsartan	Valsartan	94	33
Pregabalin	Pregabalin	90	21
Azithromycin	Azithromycin	79	70
Azelastine Hcl	Azelastine Hcl	78	24
Baclofen	Baclofen	75	34
Escitalopram Oxalate	Escitalopram Oxalate	74	30
Pioglitazone Hcl	Pioglitazone Hcl	74	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	71	43
Benzonatate	Benzonatate	69	35
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	69	26
Comfort Ez Pen Needle	Pen Needle, Diabetic	67	26
Hydrocortisone	Hydrocortisone	66	25
Sertraline Hcl	Sertraline Hcl	63	27
Finasteride	Finasteride	62	18
Hydralazine Hcl	Hydralazine Hcl	62	28
Nifedipine Er	Nifedipine	61	20
Triamcinolone Acetonide	Triamcinolone Acetonide	61	32
Atenolol	Atenolol	60	20
Bumetanide	Bumetanide	60	15
Donepezil Hcl	Donepezil Hcl	60	27
Trazodone Hcl	Trazodone Hcl	60	26
Mupirocin	Mupirocin	58	36
Diclofenac Sodium	Diclofenac Sodium	57	37
Dutasteride	Dutasteride	56	14
Dapagliflozin	Dapagliflozin Propanediol	54	17
Ketoconazole	Ketoconazole	54	25
Memantine Hcl	Memantine Hcl	52	26
Latanoprost	Latanoprost	48	12
Quetiapine Fumarate	Quetiapine Fumarate	47	19
Allopurinol	Allopurinol	43	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	38
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	43	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	42	13
Spironolactone	Spironolactone	41	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	16
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	39	13
Buspirone Hcl	Buspirone Hcl	38	15
Lansoprazole	Lansoprazole	38	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	15
Lactulose	Lactulose	35	18
Solifenacin Succinate	Solifenacin Succinate	35	15
Acyclovir	Acyclovir	33	13
Clobetasol Propionate	Clobetasol Propionate	33	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	33	14
Irbesartan	Irbesartan	32	11
Shingrix	Varicella-Zoster Ge/As01b/Pf	32	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Prednisone	Prednisone	30	14
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	27	suppressed
Ezetimibe	Ezetimibe	27	11
Potassium Chloride	Potassium Chloride	27	13
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Ibuprofen	Ibuprofen	26	16
Alogliptin	Alogliptin Benzoate	25	suppressed
Meloxicam	Meloxicam	25	12
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Amoxicillin	Amoxicillin	23	16
Alprazolam	Alprazolam	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Nystatin	Nystatin	22	15
Celecoxib	Celecoxib	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Insulin Aspart Flexpen	Insulin Aspart	21	suppressed
Mometasone Furoate	Mometasone Furoate	21	13
Myrbetriq	Mirabegron	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Methylprednisolone	Methylprednisolone	20	16
Propranolol Hcl	Propranolol Hcl	20	suppressed
Ursodiol	Ursodiol	20	suppressed
Naproxen	Naproxen	19	12
Tramadol Hcl	Tramadol Hcl	19	14
Ciclopirox	Ciclopirox	18	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	12
Mycophenolate Mofetil	Mycophenolate Mofetil	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	15
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	11
Pradaxa	Dabigatran Etexilate Mesylate	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Synjardy	Empagliflozin/Metformin Hcl	15	suppressed
Temazepam	Temazepam	15	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	11
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Fluocinonide	Fluocinonide	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Colchicine	Colchicine	12	suppressed
Estradiol	Estradiol	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Insulin Glargine Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Linzess	Linaclotide	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	11	suppressed
Topiramate	Topiramate	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error